LSTM’s Centre for Drugs & Diagnostics (CDD) manages the Medical Research Council (MRC) Impact Acceleration Account (IAA), previously Confidence in Concept (CiC) which brings together much of the UK’s expertise intropical infectious diseasesinto a single translational partnership, known as the Tropical Infectious Disease Consortium.
The Tropical Infectious Disease Consortium (TIDC) has been leading the way in turning fundamental discoveries into improvements in human health and economic benefit for tropical diseases since its establishment in 2013. The Consortium brings together much of the UK’s expertise in tropical infectious diseases into a single translational partnership from Liverpool School of Tropical Medicine (LSTM), London School of Hygiene and Tropical Medicine (LSHTM), the Jenner Institute at Oxford University (Jenner) and Public Health England (PHE). TIDC is strategically placed to deliver an unprecedented portfolio of domain specific expertise in all the key research areas of interest.
